文献速递物质与行为成瘾

靶向缰核μ阿片受体神经元减轻纳洛酮厌恶

Targeting Mu Opioid Receptor Neurons of the Habenula to Limit Naloxone Aversion.
PubMed 文献 · Biol Psychiatry · 2026-05-30

该研究在吗啡未依赖和依赖小鼠中结合纳洛酮厌恶行为模型与在体光纤记录,发现缰核μ阿片受体(Hb-MOR)神经元活性介导纳洛酮所致条件性位置厌恶。依赖状态下低剂量纳洛酮即可激活Hb-MOR神经元,化学遗传学沉默Hb-MOR神经元可减轻厌恶与躯体戒断症状。靶向GPR139拮抗剂JD-1可降低Hb-MOR对纳洛酮的反应并减轻吗啡依赖小鼠的躯体与情感戒断症状。

要点

  • Hb-MOR神经元活性介导纳洛酮诱导的条件性位置厌恶。
  • 依赖状态下Hb-MOR神经元对纳洛酮敏感性增强。
  • GPR139拮抗剂JD-1可减轻吗啡依赖小鼠戒断症状。

核心结论

  • Hb-MOR神经元是纳洛酮诱导厌恶和戒断的关键环节。
  • 药理学调控GPR139是限制纳洛酮不良反应与阿片戒断的有前景策略。

研究设计与样本

  • 研究结合纳洛酮厌恶行为模型与在体光纤记录,监测吗啡未依赖和依赖小鼠的Hb-MOR神经元活动。
  • 通过化学遗传学沉默Hb-MOR神经元检验因果性。
  • 靶向缰核富集的抗阿片孤儿受体GPR139进行药理学调控。

主要发现

  • 在吗啡未依赖小鼠中,高剂量纳洛酮诱导条件性位置厌恶(CPA)并增加Hb-MOR神经元活动,化学遗传学抑制可阻止二者。
  • 在依赖动物中,低剂量纳洛酮即足以激活Hb-MOR神经元并产生CPA。
  • 沉默Hb-MOR神经元可消除上述效应并减轻躯体戒断体征,提示依赖状态下这些神经元敏感性增强。
  • GPR139拮抗剂JD-1降低Hb-MOR对纳洛酮的反应,并减轻吗啡依赖小鼠的躯体与情感戒断症状。

临床怎么用

  • 提示Hb-MOR神经元可作为减轻纳洛酮厌恶与阿片戒断症状的潜在干预靶点。
  • GPR139药理学调控可能为限制纳洛酮相关不良反应提供新思路。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Opioid use disorder is a chronic relapsing condition that continues to rise worldwide. Naloxone, an opioid antagonist, reverses overdose but triggers strong negative affect. The neuronal circuits underlying these aversive effects remain unclear. We previously identified mu opioid receptor-expressing habenular neurons (Hb-MOR) as key encoders of negative emotional states and hypothesized that they also mediate naloxone aversion. METHODS: We combined behavioral models of naloxone aversion with in vivo fiber photometry to monitor Hb-MOR activity in opioid-naïve and -dependent mice. Causality was tested through chemogenetic silencing of Hb-MOR neurons. Finally, we targeted GPR139, an anti-opioid orphan receptor enriched in the habenula, to pharmacologically modulate naloxone responses. RESULTS: In opioid-naïve mice, high-dose naloxone induced conditioned place aversion (CPA) and increased Hb-MOR neuron activity, both of which were prevented by chemogenetic inhibition. In dependent animals, low-dose naloxone was sufficient to activate Hb-MOR neurons and produce CPA. Silencing Hb-MOR neurons abolished these effects and alleviated somatic withdrawal signs, indicating enhanced sensitivity of these neurons in dependence. Targeting GPR139 provided a therapeutic approach: The GPR139 antagonist JD-1 reduced Hb-MOR responses to naloxone and attenuated both somatic and affective withdrawal symptoms in morphine-dependent mice. CONCLUSIONS: Hb-MOR neurons are key to naloxone-induced aversion and withdrawal. Pharmacological modulation of GPR139 represents a promising strategy to limit adverse effects associated with naloxone and opioid withdrawal.

来源:Biol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Ozdemir D, Ebner C, Meyer J, et al. Targeting Mu Opioid Receptor Neurons of the Habenula to Limit Naloxone Aversion. Biol Psychiatry. 2026. PMID: 42217817. doi:10.1016/j.biopsych.2026.05.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。